ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD
Clinical trial NCT02330549 · COMPLETED
Trial details
- NCT number
- NCT02330549
- Sponsor
- Tobira Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-17
- Primary completion
- 2016-08-11
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.